Cipher Pharmaceuticals announces appointment of new CFO
by CM Staff
Mr. Jacobs has experience in financial and operational management, cost and risk management at companies across pharmaceuticals, manufacturing and technology companies in Canada.
OAKVILLE — Cipher Pharmaceuticals Inc. announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer effective August 15, 2022.
Craig Mull, Interim CEO commented on the appointment, “I am delighted to announce the addition of Mr. Jacobs to Cipher’s executive team. Bryan’s extensive experience in M&A and strategic leadership, will help fortify our management capabilities and drive our next phase of growth. Bryan brings a proven track record of senior financial expertise and enterprise success to the Company and has extensive experience in managing growth, risk management and cost efficiency programs in the manufacturing and pharmaceuticals industry. We believe that his expertise will be valuable as we focus on pursuing profitable product and business acquisitions.”
Mr. Jacobs has experience in financial and operational management, cost and risk management at companies across pharmaceuticals, manufacturing and technology companies in Canada. He is a strategic financial leader and has experience in public company compliance, financings as well as mergers and acquisitions. Mr. Jacobs holds a Bachelor’s degree in commerce is a chartered professional accountant (CPA) and chartered accountant (CA).
Current CFO Scott Langille will remain with Cipher, focusing on business development and strategic mergers and acquisitions.
